Zuess - that will be great , all my feelings are in my last post, but if I think of anything I will post to you. This is very nice of you . Thank you...
I will so much like to go to this meeting , but its just to far for me ....
If you can ask - Ask him status of 700 mg dosing - 1. Did they start dosing at 700 mg level? 2. If Yes - how many patients they intend to enroll and does he have any timeline on that? 3 if No - what is the pre-requisite to start dosing and do they need to meet with FDA to get protocol approved?when they plan to meet with FDA?
4. Do you think that you will need a new pivotal trial @ 700 mg if that dosing has no effects and shows efficacy?
Market Data 
Markets 
AI
